Therapeutic Asset Ratings

705 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Fludarabine Adrenoleukodystrophy With Cerebral Involvement	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Alpha-methylacyl-CoA Racmase Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine CBL-Related Disorder	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Central Nervous System Leukemia	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Chromosomal Disorder	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine D-Bifunctional Enzyme Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Hereditary Persistence Of Fetal Hemoglobin	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Glycoprotein Metabolic Disorders	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Transplant Rejection	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation)	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Infantile Refsum Disease	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine B-Lymphoblastic Leukemia/Lymphoma With IAMP21	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Mitochondrial Neurogastrointestingal Encephalopathy	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Monosomy 7 Myelodysplasia And Leukemia Syndrome 1	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Multifunctional Enzyme Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Neonatal Adrenoleukodystrophy	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Neurofibromatosis Type 1	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine NF1 Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Niemann-Pick B	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Niemann-Pick C Subtype 2	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine N-RAS Gene Amplification	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine PTPN11 Gene Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Recessive Leukodystrophies	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Somatic Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Sphingomyelin Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)

Showing 351 to 375 of 705 assets

PreviousPage 15 of 29Next